My supplement list and mTor pathways ... - Advanced Prostate...

Advanced Prostate Cancer

21,035 members26,216 posts

My supplement list and mTor pathways role In metastatic prostate cancer.

No_stone_unturned profile image

More and more I’m seeing a connection between the mTor pathway and metastatic prostate cancer. I just got my advanced genetic testing results back and was told…”you guessed it,” an mTor mutation. My purpose of this post is two fold:

1) To share my list of supplements for those looking for a jumping off point for what I find to be the most promising.

2) To start a discussion on mTor inhibitors and evaluate real world success or failure rates.

Written by
No_stone_unturned profile image
No_stone_unturned
To view profiles and participate in discussions please or .
Read more about...
8 Replies

youthandearth.com/blogs/blo...

(also apologies, noticed I posted the same list twice it is now corrected)

Supplement list part 2
No_stone_unturned profile image
No_stone_unturned in reply to No_stone_unturned

ncbi.nlm.nih.gov/pmc/articl...

KocoPr profile image
KocoPr in reply to No_stone_unturned

I’ve read the article but it is from 2009.

You may already know this but it might help some that don’t.

Here is a better way to get the latest articles that are cited by the older articles.

I put old article title in search engine with pubmed and then scroll to bottom of article to “cited by”

here is one of several recent articles on same subject.

pubmed.ncbi.nlm.nih.gov/350...

AbstractDeregulation of the PI3K-Akt-mTOR pathway plays a critical role in the development and progression of many cancers. In prostate cancer, evidence suggests that it is mainly driven by PTEN loss of function. For many years, the development of selective Akt inhibitors has been challenging. In recent phase II and III clinical trials, Ipatasertib and Capivasertib associated with androgen deprivation therapies showed promising outcomes in patients with metastatic castration-resistant prostate cancer and PTEN-loss. Ongoing trials are currently assessing several Akt inhibitors in prostate cancer with different combinations, at different stages of the disease.

No_stone_unturned profile image
No_stone_unturned in reply to KocoPr

Thank you for the feedback. I ran it by my MO and here was his response:

Conversation with oncologist
tango65 profile image
tango65

Ipatasertib may work in delaying the progression of mCRPC with PTEN loss

thelancet.com/journals/lanc...

noahware profile image
noahware

I believe a time-restricted, low-cal/low-protein keto diet can help inhibit mTOR.

KocoPr profile image
KocoPr in reply to noahware

from what I have just read on this is mTOR pathway has sevrral positive and negative feedback loops making it very difficult to use mono inhibitors.

Published: 10 March 2020mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

cellandbioscience.biomedcen...

sirolimus is an rx correct?

You may also like...

Supplements for metastatic prostate cancer

there a list of supplements that are safe to take after initial treatment for metastatic prostate...

Update On My Metastatic Prostate Cancer

Lupron after that be advisable? Or, with metastatic prostate cancer, I should continue with Lupron...

My Dad's Metastatic Prostate Cancer Update

ago or more. He's on Zytiga + Prednisone.. he has MCRPC (metastatic castrate resistant prostate...

An Update of ADT2 Treatment for My Metastatic Prostate Cancer

days moderately strong. Throughout the day I get more episodes at random. I never had any...

Advanced Metastatic Prostate Cancer

June 2016, I was diagnosed with advanced metastatic (gleason 9) prostate cancer. The cancer spread...